nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—HTR6—forebrain—narcolepsy	0.0147	0.113	CbGeAlD
Dihydroergotamine—Ergotamine—HTR2A—narcolepsy	0.0107	0.509	CrCbGaD
Dihydroergotamine—Bromocriptine—HTR2A—narcolepsy	0.0103	0.491	CrCbGaD
Dihydroergotamine—HTR1B—brainstem—narcolepsy	0.00919	0.0704	CbGeAlD
Dihydroergotamine—HTR1D—brainstem—narcolepsy	0.0089	0.0681	CbGeAlD
Dihydroergotamine—HTR1B—forebrain—narcolepsy	0.00887	0.0679	CbGeAlD
Dihydroergotamine—HTR1D—forebrain—narcolepsy	0.00859	0.0658	CbGeAlD
Dihydroergotamine—HTR2B—forebrain—narcolepsy	0.00799	0.0612	CbGeAlD
Dihydroergotamine—HTR1A—brainstem—narcolepsy	0.00742	0.0568	CbGeAlD
Dihydroergotamine—HTR1A—forebrain—narcolepsy	0.00716	0.0548	CbGeAlD
Dihydroergotamine—HTR6—brain—narcolepsy	0.00611	0.0468	CbGeAlD
Dihydroergotamine—HTR1B—midbrain—narcolepsy	0.00586	0.0449	CbGeAlD
Dihydroergotamine—HTR1D—midbrain—narcolepsy	0.00567	0.0434	CbGeAlD
Dihydroergotamine—ADRA2A—forebrain—narcolepsy	0.00502	0.0384	CbGeAlD
Dihydroergotamine—HTR1A—midbrain—narcolepsy	0.00473	0.0362	CbGeAlD
Dihydroergotamine—HTR1B—brain—narcolepsy	0.00368	0.0282	CbGeAlD
Dihydroergotamine—ADRA2A—medulla oblongata—narcolepsy	0.00362	0.0278	CbGeAlD
Dihydroergotamine—HTR1D—brain—narcolepsy	0.00356	0.0273	CbGeAlD
Dihydroergotamine—HTR2B—brain—narcolepsy	0.00331	0.0254	CbGeAlD
Dihydroergotamine—ADRA2A—midbrain—narcolepsy	0.00331	0.0254	CbGeAlD
Dihydroergotamine—HTR1A—brain—narcolepsy	0.00297	0.0227	CbGeAlD
Dihydroergotamine—ABCB1—forebrain—narcolepsy	0.0028	0.0214	CbGeAlD
Dihydroergotamine—ADRA2A—brain—narcolepsy	0.00208	0.0159	CbGeAlD
Dihydroergotamine—ABCB1—medulla oblongata—narcolepsy	0.00202	0.0155	CbGeAlD
Dihydroergotamine—HTR2B—GPCR ligand binding—TRH—narcolepsy	0.00185	0.00218	CbGpPWpGaD
Dihydroergotamine—ABCB1—midbrain—narcolepsy	0.00185	0.0141	CbGeAlD
Dihydroergotamine—HTR6—GPCR downstream signaling—HCRTR2—narcolepsy	0.00184	0.00217	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HCRTR1—narcolepsy	0.00184	0.00217	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00183	0.00215	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00182	0.00215	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00182	0.00215	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00182	0.00214	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.0018	0.00212	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00179	0.0021	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00179	0.0021	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—P2RY11—narcolepsy	0.00177	0.00209	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—HRH3—narcolepsy	0.00177	0.00209	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00176	0.00208	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00176	0.00208	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.00176	0.00208	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00176	0.00208	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—HRH3—narcolepsy	0.00176	0.00208	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00172	0.00203	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—P2RY11—narcolepsy	0.00172	0.00203	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—HRH3—narcolepsy	0.00172	0.00203	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.0017	0.00201	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00168	0.00198	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00168	0.00198	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00168	0.00198	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HCRTR2—narcolepsy	0.00167	0.00197	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HCRTR1—narcolepsy	0.00167	0.00197	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00166	0.00195	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00166	0.00195	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00162	0.00191	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00162	0.00191	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00162	0.00191	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—HRH3—narcolepsy	0.00162	0.00191	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—P2RY11—narcolepsy	0.00161	0.0019	CbGpPWpGaD
Dihydroergotamine—HTR2B—G alpha (q) signalling events—HTR2A—narcolepsy	0.0016	0.00189	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—P2RY11—narcolepsy	0.0016	0.00188	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00158	0.00186	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—P2RY11—narcolepsy	0.00157	0.00185	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00155	0.00183	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00155	0.00182	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00152	0.00179	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00152	0.00179	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HCRT—narcolepsy	0.00151	0.00178	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.0015	0.00177	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.0015	0.00177	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HCRT—narcolepsy	0.0015	0.00176	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—P2RY11—narcolepsy	0.00147	0.00173	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—TAC1—narcolepsy	0.00147	0.00173	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—NPS—narcolepsy	0.00147	0.00173	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HCRT—narcolepsy	0.00147	0.00173	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—TAC1—narcolepsy	0.00146	0.00172	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—NPS—narcolepsy	0.00146	0.00172	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00143	0.00169	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—NPS—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—TAC1—narcolepsy	0.00143	0.00168	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00138	0.00163	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HCRT—narcolepsy	0.00138	0.00162	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HCRT—narcolepsy	0.00137	0.00161	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00136	0.0016	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00136	0.0016	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HCRT—narcolepsy	0.00136	0.0016	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00136	0.0016	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00136	0.0016	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00135	0.00159	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—PENK—narcolepsy	0.00134	0.00158	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—TAC1—narcolepsy	0.00134	0.00158	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—NPS—narcolepsy	0.00134	0.00158	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—PENK—narcolepsy	0.00133	0.00157	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HCRT—narcolepsy	0.00133	0.00157	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00132	0.00155	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00131	0.00155	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.00131	0.00155	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—PENK—narcolepsy	0.00131	0.00154	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00128	0.00151	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HCRT—narcolepsy	0.00125	0.00147	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00124	0.00146	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00123	0.00146	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00123	0.00146	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—PENK—narcolepsy	0.00123	0.00145	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—PENK—narcolepsy	0.00122	0.00144	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.00121	0.00143	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.00119	0.00141	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.00119	0.0014	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00118	0.00139	CbGpPWpGaD
Dihydroergotamine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00116	0.00137	CbGpPWpGaD
Dihydroergotamine—ABCB1—brain—narcolepsy	0.00116	0.00888	CbGeAlD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00115	0.00136	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—TRH—narcolepsy	0.00114	0.00135	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.00113	0.00134	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00113	0.00133	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00112	0.00132	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00112	0.00132	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00112	0.00132	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—PENK—narcolepsy	0.00111	0.00131	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.00111	0.00131	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.00109	0.00128	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.00109	0.00128	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00107	0.00126	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00107	0.00126	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00106	0.00125	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—TRH—narcolepsy	0.00104	0.00123	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—TRH—narcolepsy	0.00104	0.00122	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00103	0.00122	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00103	0.00122	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.00103	0.00121	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.00101	0.0012	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.00101	0.00119	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.001	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HRH3—narcolepsy	0.001	0.00118	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.000995	0.00117	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.000995	0.00117	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HCRTR1—narcolepsy	0.000986	0.00116	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HCRTR2—narcolepsy	0.000986	0.00116	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.000978	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.000978	0.00115	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.000974	0.00115	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.000971	0.00114	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.000971	0.00114	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.000958	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.000958	0.00113	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—P2RY11—narcolepsy	0.000952	0.00112	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—TRH—narcolepsy	0.000948	0.00112	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.000945	0.00111	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.000937	0.0011	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.000925	0.00109	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HRH3—narcolepsy	0.000915	0.00108	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HRH3—narcolepsy	0.00091	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.000904	0.00107	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.000904	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HCRTR2—narcolepsy	0.0009	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HCRTR1—narcolepsy	0.0009	0.00106	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.000885	0.00104	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—HTR2A—narcolepsy	0.000884	0.00104	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.000878	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.000878	0.00103	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—P2RY11—narcolepsy	0.000869	0.00102	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00086	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.000859	0.00101	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.000855	0.00101	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.000855	0.00101	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.000846	0.000998	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HRH3—narcolepsy	0.000831	0.00098	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—NPS—narcolepsy	0.000831	0.000979	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—TAC1—narcolepsy	0.000831	0.000979	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.000824	0.000972	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.000824	0.000972	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HCRT—narcolepsy	0.000809	0.000954	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.000807	0.000952	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.000807	0.000952	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—HTR2A—narcolepsy	0.000807	0.000951	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.000803	0.000947	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.000797	0.00094	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000789	0.00093	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.000786	0.000927	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.000782	0.000922	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CHKB—narcolepsy	0.000779	0.000918	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.000769	0.000906	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—TAC1—narcolepsy	0.000758	0.000894	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—NPS—narcolepsy	0.000758	0.000894	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—TAC1—narcolepsy	0.000754	0.000889	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—NPS—narcolepsy	0.000754	0.000889	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.000749	0.000882	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.000749	0.000882	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.000742	0.000875	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HCRT—narcolepsy	0.000739	0.000871	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—NPS—narcolepsy	0.000733	0.000864	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—TAC1—narcolepsy	0.000733	0.000864	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.00073	0.00086	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.00073	0.00086	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PENK—narcolepsy	0.000721	0.00085	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PENK—narcolepsy	0.000716	0.000844	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.00071	0.000837	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.000705	0.00083	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PENK—narcolepsy	0.000701	0.000826	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—NPS—narcolepsy	0.000689	0.000812	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—TAC1—narcolepsy	0.000689	0.000812	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000676	0.000796	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.000674	0.000794	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.000665	0.000784	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PENK—narcolepsy	0.000658	0.000776	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.000655	0.000772	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000645	0.000761	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	0.000615	0.000725	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—NPS—narcolepsy	0.000615	0.000725	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TRH—narcolepsy	0.000613	0.000723	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TRH—narcolepsy	0.000609	0.000717	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000604	0.000712	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.000604	0.000712	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HCRT—narcolepsy	0.000599	0.000706	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TRH—narcolepsy	0.000596	0.000703	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.000583	0.000688	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.000573	0.000676	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.000573	0.000676	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TRH—narcolepsy	0.00056	0.00066	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—TAC1—narcolepsy	0.000558	0.000658	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—NPS—narcolepsy	0.000558	0.000658	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.000554	0.000653	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CHKB—narcolepsy	0.000539	0.000635	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HRH3—narcolepsy	0.000538	0.000634	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PENK—narcolepsy	0.000534	0.000629	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HRH3—narcolepsy	0.000534	0.000629	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.00053	0.000624	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Metabolism—CPT1B—narcolepsy	0.000529	0.000624	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HRH3—narcolepsy	0.000523	0.000616	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.000515	0.000606	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—HTR2A—narcolepsy	0.0005	0.000589	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	0.000496	0.000585	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HRH3—narcolepsy	0.000491	0.000579	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	0.000486	0.000572	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.000483	0.00057	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.000483	0.00057	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.000471	0.000555	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000456	0.000538	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TRH—narcolepsy	0.000454	0.000535	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—HTR2A—narcolepsy	0.000454	0.000535	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	0.00045	0.000531	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NPS—narcolepsy	0.000446	0.000525	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TAC1—narcolepsy	0.000446	0.000525	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NPS—narcolepsy	0.000442	0.000521	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TAC1—narcolepsy	0.000442	0.000521	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	0.000441	0.00052	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.000439	0.000517	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.000439	0.000517	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TAC1—narcolepsy	0.000433	0.00051	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NPS—narcolepsy	0.000433	0.00051	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.00042	0.000495	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—HTR2A—narcolepsy	0.000414	0.000488	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TAC1—narcolepsy	0.000407	0.000479	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NPS—narcolepsy	0.000407	0.000479	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HRH3—narcolepsy	0.000398	0.000469	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.00037	0.000436	CbGpPWpGaD
Dihydroergotamine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000366	0.000432	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.000357	0.000421	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	0.000336	0.000396	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CHKB—narcolepsy	0.000332	0.000391	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TAC1—narcolepsy	0.00033	0.000389	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NPS—narcolepsy	0.00033	0.000389	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000313	0.000369	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000298	0.000352	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000291	0.000343	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—HTR2A—narcolepsy	0.000268	0.000316	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—HTR2A—narcolepsy	0.000266	0.000314	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000264	0.000311	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—HTR2A—narcolepsy	0.000261	0.000307	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000259	0.000306	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000259	0.000306	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—HTR2A—narcolepsy	0.000245	0.000288	CbGpPWpGaD
Dihydroergotamine—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000226	0.000266	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—HTR2A—narcolepsy	0.000198	0.000234	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.000156	0.000184	CbGpPWpGaD
